Therapeutic effects of atorvastatin on serum lipids and C - reactive protein in patients with acute coronary syndrome at the early stage
刘军委
Abstract
刘军委
Abstract
Objective To explore the effects of atorvastatin on serum C - reactive protein in pa-tients with acute coronary syndrome(ACS). Methods Seventy cases of ACS patients were randomly di-vided into atorvastatin group (n = 35) and control group (n = 35). The serum CRP and lipoprotein were measured in 70 patients with ACS before and after treatment. Results After 4 weeks, the atorvastatin-group and control group, patients with CRP and serum total cholesterol (TC), triglycerides (TG) and low - density lipoprotein cholesterol (LDL - C) concentration decreased significantly (P 0.05). Conclusions The serum levels of CRP are increased in patients with ACS. Atorvastatin is an effective and safe lipid -lowering drug, it can decrease CliP and increase HDL- C in plasma level. Key words: Atorvastatin ; C - reactive protein ; Coronary disease ;
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effects of atorvastatin on serum C - reactive protein in pa-tients with acute coronary syndrome(ACS). Methods Seventy cases of ACS patients were randomly di-vided into atorvastatin group (n = 35) and control group (n = 35). The serum CRP and lipoprotein were measured in 70 patients with ACS before and after treatment. Results After 4 weeks, the atorvastatin-group and control group, patients with CRP and serum total cholesterol (TC), triglycerides (TG) and low - density lipoprotein cholesterol (LDL - C) concentration decreased significantly (P 0.05). Conclusions The serum levels of CRP are increased in patients with ACS. Atorvastatin is an effective and safe lipid -lowering drug, it can decrease CliP and increase HDL- C in plasma level. Key words: Atorvastatin ; C - reactive protein ; Coronary disease ;
Key concepts: Atorvastatin, Acute coronary syndrome, C-reactive protein, Medicine, Internal medicine, Lipoprotein, Gastroenterology, Coronary heart disease